Melmon and Morrelli's Clinical Pharmacology: Basic Principles in Therapeutics
McGraw Hill Professional, 2000 - 1433 Seiten
Comprehensive and current, this one-of-a-kind resource offers students and practitioners an ideal reference in therapeutic drug decision-making. . . Melmon and Morrelli's Clinical Pharmacology builds the necessary links among scientific principles, fact-based evidence, and clinical experience. Designed to aid physicians at all levels in improving the quality of treatment and providing optimal pharmotherapeutic plans for patients, this resource outlines a problem-based approach to drug therapy that emphasizes the rationale behind it.. . Fully updated to keep pace with advances in medicine, Melmon and Morrelli's Clinical Pharmacology is 75% new and substantially revised, with new coverage of antimicrobials, drug kinetics and dynamics, drug interactions, and more. With chapters written by leading international experts in many therapeutic fields, this resource provides: . . *In-depth discussions of the principles of therapeutic choice that apply across multiple types of treatment. *Chapters on drug treatments for pulmonary, infectious, cardiovascular, psychiatric, hematologic diseases, and other areas frequently encountered in internal medicine. *Coverage of special-case scenarios, such as stages of life and patients with various drug needs. *Easy-to-find practical information on evidence of effectiveness, toxicity, cost/benefit ratios, acute effects, and long-term outcomes.
3 Seiten stimmen mit dem Suchbegriff "aurothiomalate" in diesem Buch überein.
Was andere dazu sagen - Rezension schreiben
Es wurden keine Rezensionen gefunden.
INTRODUCTION TO CLINICAL PHARMACOLOGY
H A P T E R 1
45 weitere Abschnitte werden nicht angezeigt.
3-adrenergic ACE inhibitors acid action activity acute administration adverse effects agents agonists amiodarone angina antibiotics arrhythmias artery aspirin associated asthma atrial fibrillation benefit beta-blockers blockers blood pressure bronchodilators calcium channel cardiac cause cells cholesterol chronic Clin clinical trials concentrations coronary corticosteroids decrease diabetes diagnosis diltiazem disease disorders diuretics dopamine dose double-blind dysfunction efficacy Engl enzyme excretion fibrosis glucose heart failure heparin hepatic hypertension hypotension improve increased infection inhaled inhibition insulin intravenous ischemic kidney Lancet lipoprotein liver long-term loop diuretics lung mechanisms medications metabolism metformin mg/day mortality myasthenia gravis myocardial infarction occur oral orthostatic orthostatic hypotension patients pharmacokinetics pharmacologic physician placebo plasma potential prevention PRINCIPLE protein pulmonary randomized reactions receptor antagonists reduce regimen renal function response risk factors seizures serum sodium stroke Study Group sulfonylureas symptoms syndrome Table tachycardia tacrine therapeutic thiazide tients tion toxicity treated treatment vascular vasodilators venous ventricular verapamil vitamin warfarin